Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Reimbursement Experts of PBM Services in Disease Management(?)

Council Members in this Study Group: 39

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

David Zimmerman, PharmD
President/Owner
Doctors of Pharmacy, Inc.

David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy, Inc. Dr. Zimmerman formerly served as the Director of Clinical Affairs at Employee Health Insurance Management, a pharmacy benefit manager. He has over 30 years of experience, specializing in pharmacy...

Aemad Aslam, MBA
President
MindPharma

Aemad Aslam, BPharm, MBA, RPh, is the President of MindPharma, a pharmacy and retail strategy consulting group. Most recently, he has consulted with a PBM, Prime Therapeutics, in Texas, a subsidiary of Blue Cross Blue Shield. He also has served as an Executive Team Leader for Pharmacy at the Target...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Tamper Proof Narcotic Pain pill? YES | 11-13-2008
Analysis of: FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
Author: David Zimmerman, PharmD, President/Owner, Doctors of Pharmacy, Inc.

This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.

Fosamax generic... | 02-11-2008
Analysis of: Teva wins FDA OK to sell generic Fosamax | www.reuters.com
Author: David Zimmerman, PharmD, President/Owner, Doctors of Pharmacy, Inc.

It is important to understand the generic implications when it comes to drug product olacement on the formulary.

Zyprexa safety | 02-11-2008
Author: David Zimmerman, PharmD, President/Owner, Doctors of Pharmacy, Inc.

This article is informative because it draws conclusions about Zyprexa.

daily use Cialis---a good idea! | 01-11-2008
Analysis of: Cialis Is Cleared for Daily Use | online.wsj.com
Author: David Zimmerman, PharmD, President/Owner, Doctors of Pharmacy, Inc.

    Physicians have been prescribing lower dose Cialis...off label... for a long time. The FDA finally agreed and approved it.

A can of tennis balls? | 10-19-2007
Author: David Zimmerman, PharmD, President/Owner, Doctors of Pharmacy, Inc.

Exubera is a great product. However, the delivery system was difficult to use and educate the patients how to use. Hopefully, the next generation of the product will be in a smaller more user friendly cannister.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Pharmaceutical Benefits Manager, Small <10 M Lives
  • Pharmaceutical Benefits Manager, Large >10 M Lives
  • Consultancy, Pharma-Focused
  • Academic Institution*

Most Common Job Types:

  • Director
  • Pharmacist - RPh/PharmD
  • Consultant
  • Operations Executive
  • President

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-05T01:45:24.617